Wilms tumour survival rate & prognosis — what parents need to know
A Wilms tumour diagnosis — also called nephroblastoma — is frightening for any family. But it is important to know: Wilms tumour is one of the most treatable childhood cancers. With the right multi-disciplinary care, most children do very well. Understanding the factors that shape prognosis helps you ask the right questions and feel confident about next steps.
- Wilms tumour survival rate — shaped by stage, tumour histology, and completeness of surgical removal
- Nephroblastoma cure rate — favourable-histology tumours at early stages carry excellent long-term outcomes
- Comprehensive tumour board — every CION child's case reviewed by surgical, medical, and radiation specialists together
- 45-minute first consultation — time to understand the diagnosis, review scans, and plan next steps without being rushed
Medically reviewed by Dr. N. Kiranmayee, Medical Oncologist, CION Cancer Clinics · Last reviewed June 2026
on Panel
Survival Rate*
Treated
(800+ reviews)
What the survival rate for Wilms tumour actually means
When you search for a Wilms tumour survival rate, you find numbers from large international registries — figures collected from thousands of children treated over many years. These numbers represent the proportion of children alive at a defined point, most often five years, after diagnosis. They are the most reliable scientific picture we have of how Wilms tumour behaves as a whole — but they are a starting point, not a prediction for your child.
The most important thing to understand is this: Wilms tumour is among the most successfully treated solid tumours in children. Decades of carefully coordinated international clinical research — particularly through NWTS (National Wilms Tumor Study) and SIOP (International Society of Paediatric Oncology) trials — have produced treatment approaches that work for the great majority of children. Most children diagnosed today, even at advanced stages, are treated with curative intent.
What shapes your child's individual outlook is not the population figure but the specific characteristics of their tumour — the stage at diagnosis, the histological type, whether it can be completely removed with surgery, and how the tumour responds to treatment. Your oncologist builds a personalised assessment from all of these, not from a table.
At CION Cancer Clinics, every child with a kidney tumour is reviewed at a dedicated tumour board — medical, surgical, and radiation oncologists together. We give families a full 45-minute consultation to understand the diagnosis, go through the scans, and make thoughtful decisions. No rushed answers. Decisions for healing, not billing.
How stage shapes Wilms tumour prognosis
Stage is the most important single predictor of outcome in Wilms tumour. Staging describes how far the tumour has grown or spread at the time of diagnosis. It determines treatment intensity and guides the team's goals. Below is an overview of what each stage means — your child's oncologist will explain the specific implications for your child.
Stage I — Tumour confined to the kidney
The tumour is contained entirely within the kidney and is completely removed by surgery. There is no spread to nearby lymph nodes or other organs, and the surgical margin is clear. Stage I favourable-histology Wilms tumour carries excellent outcomes. Treatment after surgery typically involves a shorter course of chemotherapy. Children at this stage generally recover well and are followed up to monitor kidney function and watch for any recurrence.
Stage II — Local spread, fully removed
The tumour has extended beyond the kidney — into the surrounding fat, blood vessels, or nearby tissue — but the surgeon has been able to remove it completely with clear margins. Lymph nodes remain negative. Stage II disease requires chemotherapy after surgery, with the regimen chosen based on histology. Most children with Stage II favourable-histology tumours do very well with standard treatment. Close monitoring continues after therapy is complete.
Stage III — Residual disease in the abdomen
Stage III means the tumour has spread to regional lymph nodes, or there is residual tumour in the abdomen after surgery that could not be fully removed, or there was tumour spillage during the operation. Treatment is more intensive — surgery plus multi-agent chemotherapy plus radiation to the abdomen. Despite the more intensive approach, many children with Stage III disease achieve complete remission. Histology continues to guide the exact protocol.
Stage IV — Spread to distant organs
The cancer has spread (metastasised) to distant organs — most commonly the lungs, and less often the liver or other sites. Stage IV requires the most intensive treatment: surgery on the primary kidney tumour, multi-agent chemotherapy, and usually radiation to the lungs (whole-lung radiation) and/or the abdomen. A meaningful proportion of children with Stage IV favourable-histology Wilms tumour achieve sustained remission with this approach. Expert multi-disciplinary management is especially important at this stage.
Stage V — Both kidneys involved
Bilateral Wilms tumour — affecting both kidneys simultaneously — is seen in roughly 5% of cases. The treatment goal shifts to removing as much tumour as possible while preserving enough healthy kidney tissue for normal kidney function in the future. Surgery is carefully planned after pre-surgical chemotherapy to shrink the tumours. This is among the most complex presentations and requires an experienced centre with expertise in bilateral kidney-sparing surgery and careful long-term kidney monitoring.
Favourable vs unfavourable histology
Across all stages, tumour histology — what the cells look like under the microscope — significantly affects treatment intensity and outlook. The great majority of Wilms tumours have favourable histology, meaning no anaplasia (cell disorganisation). Tumours with unfavourable histology (anaplasia, particularly diffuse anaplasia) require more aggressive chemotherapy protocols and are associated with a higher risk of treatment resistance. The pathologist's report after surgery or biopsy is essential for this determination.
Stage is determined after imaging (ultrasound, CT scan) and confirmed at surgery. Pre-surgical chemotherapy (used in the SIOP approach for large tumours) may alter the final pathological stage. Your child's team will explain which staging system they use and what it means for the specific treatment plan.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a plan built around their tumour — not a generic protocol
Every Wilms tumour is different. Our tumour board reviews each case together — surgical, medical, and radiation oncologists in one room — so treatment decisions are informed by the full picture, not one doctor's view.
How Wilms tumour treatment works — step by step
Treatment for Wilms tumour is multi-disciplinary — surgery, chemotherapy, and sometimes radiation work together. Understanding each component helps parents know what to expect, why each step matters, and how the team makes decisions along the way.
Diagnosis and staging — building the complete picture
Before any treatment, the team needs to understand exactly what they are dealing with. This involves an ultrasound and CT scan of the abdomen and chest to assess the tumour's size, the state of the opposite kidney, and whether the cancer has spread to the lungs or elsewhere. Blood and urine tests assess kidney function. Some centres also perform a core needle biopsy before surgery; others proceed directly to surgery based on imaging. The staging process takes a few days and results in a treatment plan tailored to your child's specific findings.
Surgery — removing the tumour and staging the disease
Surgery is the cornerstone of Wilms tumour treatment. In most cases, the surgeon removes the entire affected kidney (radical nephrectomy) along with the tumour, surrounding tissue, and nearby lymph nodes. Lymph node sampling at surgery is critically important because it determines the final stage and guides whether radiation is needed. For bilateral tumours (Stage V) or very large tumours, pre-surgical chemotherapy is given first to shrink the tumour before operating. The surgical specimen is then examined by a pathologist to determine histology (favourable or unfavourable), which refines the treatment plan further.
Chemotherapy — eliminating remaining cancer cells
After surgery, all children with Wilms tumour receive chemotherapy. The combination of medicines, the number of cycles, and the total duration depend on stage and histology. Stage I and II favourable-histology tumours are treated with a shorter regimen using two medicines; Stage III and Stage IV disease requires a longer course with three or more medicines. Most chemotherapy is given in an outpatient setting, meaning your child does not need to be admitted to hospital for every cycle. Side effects are monitored closely, and your team will have clear guidance on what symptoms to watch for at home between visits.
Radiation therapy — used selectively for higher-stage disease
Radiation to the abdomen (flank or whole-abdomen) is added for Stage III disease and for any stage with unfavourable histology, to target residual cancer in the operative area. For Stage IV disease with lung metastases, whole-lung radiation is considered, particularly if the lung lesions do not fully disappear after chemotherapy. Modern radiation planning in children is done with extreme care to minimise long-term effects on growing organs. Radiation is not used for Stage I or Stage II favourable-histology tumours, where chemotherapy alone is sufficient.
Follow-up and long-term monitoring
After treatment ends, structured follow-up continues for several years. Imaging of the chest and abdomen is done at regular intervals to detect any recurrence early. Kidney function — blood pressure, urine protein, and blood tests — is monitored because the remaining kidney carries extra workload and because some medicines can affect kidney health over time. Children who received abdominal radiation are watched for any effects on nearby structures. The long-term goal is not just cure but a healthy, full life — your child's follow-up team is focused on both.
Factors that shape your child's Wilms tumour prognosis
These are the well-established clinical and pathological factors your oncologist considers when planning treatment and explaining your child's outlook. No single factor tells the whole story — the team weighs all of them together.
| Prognostic factor | More favourable | Less favourable |
|---|---|---|
| Stage at diagnosis | Stage I or II — tumour confined to or near the kidney, fully removed | Stage III, IV or V — lymph node involvement, distant metastasis, or bilateral disease |
| Tumour histology | Favourable histology — no anaplasia present | Unfavourable histology — focal or diffuse anaplasia (diffuse anaplasia carries the highest risk) |
| Surgical margins | Complete resection with clear margins (R0) | Positive or close margins; tumour spillage at surgery |
| Lymph node status | Negative lymph nodes at surgery | Positive regional lymph nodes (upstages to at least Stage III) |
| Tumour size | Smaller tumour — lower operative complexity | Large tumour — may require pre-surgical chemotherapy; higher spill risk |
| Response to pre-surgical chemotherapy | Marked tumour shrinkage (SIOP good responder) | Limited response — may indicate higher-risk biology |
| Age at diagnosis | Age 1–5 years — typical Wilms tumour peak | Under 6 months (may have different biology); adolescent onset is less common |
| Lung metastasis response | Complete resolution on imaging after chemotherapy | Persistent lung lesions — requires whole-lung radiation |
This table summarises well-established prognostic factors from international paediatric oncology guidelines (COG, SIOP). It is not a substitute for a personalised assessment by your child's oncologist, who will weigh all relevant findings together.
You deserve a team that walks this journey with you
From first diagnosis through surgery, chemotherapy, and long-term follow-up — our paediatric oncology team is with your family at every step. Transparent costs, no unnecessary tests, and a plan built for your child.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Questions parents ask about Wilms tumour prognosis
What is the survival rate for Wilms tumour?
Wilms tumour (nephroblastoma) has one of the most favourable outcomes of any childhood cancer. In well-resourced treatment centres, the great majority of children diagnosed with Wilms tumour — particularly those at early stages — achieve long-term remission. Outcomes are meaningfully shaped by stage at diagnosis, tumour histology (whether the tumour is favourable or unfavourable type), and whether the cancer has spread beyond the kidney.
Your child's oncologist will explain what the published outcome data means for your child's specific situation, because individual factors matter far more than population averages.
Does the stage of Wilms tumour affect survival?
Yes — stage is one of the most important factors in Wilms tumour prognosis. Stage I and Stage II tumours, where the cancer is still confined to or very close to the kidney and can be completely removed by surgery, carry substantially better outcomes than Stage IV or Stage V disease, where the cancer has spread to distant organs (such as the lungs or liver) or involves both kidneys.
Even in advanced stages, treatment — combining surgery, chemotherapy, and sometimes radiation — can be effective, and many children with Stage IV disease achieve sustained remission. The key is prompt, expert multi-disciplinary care.
What does tumour histology (favourable vs unfavourable) mean for Wilms prognosis?
Histology refers to what the tumour cells look like under the microscope after a pathologist examines the biopsy or surgically removed kidney. Favourable histology (the large majority of Wilms tumours) means the cells look relatively normal in structure and do not show the specific abnormality called anaplasia. Unfavourable histology — specifically anaplasia, which indicates irregular, disorganised cell nuclei — is seen in a minority of tumours and is associated with a lower response to standard treatment.
Children with anaplastic Wilms tumour generally receive more intensive chemotherapy protocols. The distinction is made by the pathologist after surgery or biopsy, not by scans.
What is the treatment for Wilms tumour and how long does it take?
Treatment for Wilms tumour typically involves three main components: surgery, chemotherapy, and in some cases radiation therapy. Surgery (nephrectomy — removal of the affected kidney) is the cornerstone and is usually performed early, though in bilateral disease or very large tumours some centres use pre-surgical chemotherapy first to shrink the tumour.
Chemotherapy uses a combination of medicines given over several months; the specific regimen and duration depend on stage and histology. Radiation is added for Stage III or IV disease and for unfavourable histology. Total treatment duration ranges from approximately 18 weeks for early-stage favourable-histology tumours to longer courses for high-risk disease. The remaining kidney is sufficient for normal life.
Can a child live normally with one kidney after Wilms tumour treatment?
Yes. The vast majority of children who undergo nephrectomy for Wilms tumour go on to live full, healthy lives with their single remaining kidney. The remaining kidney compensates over time through a process called compensatory hypertrophy, and kidney function is typically well preserved into adulthood.
Long-term follow-up care does include periodic kidney function monitoring and blood pressure checks, because the remaining kidney carries extra workload and because some chemotherapy medicines can affect kidney health over time. Children are also advised to protect their remaining kidney from trauma during contact sports — a simple precaution, not a restriction on a full, active life.
My child has been diagnosed with Wilms tumour — what should I do next?
The most important step is to get your child evaluated at a centre experienced in paediatric oncology. Wilms tumour requires a coordinated team — a paediatric surgical oncologist, a medical oncologist, a radiation oncologist, and a pathologist — working together from the day of diagnosis.
Bring all available imaging (ultrasound, CT scan) and blood test reports to the first consultation. At CION Cancer Clinics, every child's case is reviewed at a dedicated tumour board, so your child's plan is not one doctor's opinion but a team decision. The first consultation is free — call 1800 202 8726 or book online. Early, expert evaluation leads to the best possible outcomes.
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.